Search Results for keywords:"charter expiration"

Found 2 results

Search Results: keywords:"charter expiration"

💰 Only
Oldest Newest
  • 2024-29231 — Advisory Committee; Science Board to the Food and Drug Administration; Renewal
    Type:Notice
    Citation:89 FR 100507
    Reading Time:about 4 minutes

    The Food and Drug Administration (FDA) has announced the renewal of its Science Board, extending its charter until June 26, 2026. This board provides expert advice to the FDA on various complex scientific and technical issues crucial to the agency's mission, including areas like food safety, pharmacology, and public health. The board consists of 21 voting members, with additional members or consultants temporarily added as necessary for specific expertise. The renewal confirms that it is in the public interest to maintain this advisory board for at least two more years.

    Simple Explanation

    The FDA has decided to keep a special group of experts, called the Science Board, working for two more years to help them with tricky science stuff like keeping food and medicine safe. This group of experts gives important advice to help the FDA do its job better.

  • 2024-31363 — Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee; Renewal
    Type:Notice
    Citation:89 FR 107148
    Reading Time:about 3 minutes

    The Food and Drug Administration (FDA) has announced the renewal of the Dermatologic and Ophthalmic Drugs Advisory Committee, which will now operate until October 7, 2026. The committee provides expert advice on the safety and effectiveness of drugs used to treat skin and eye conditions, ensuring they are safe for human use. The committee is made up of professionals from various medical fields, including dermatology and ophthalmology, who are selected by the FDA Commissioner. This renewal highlights the FDA's commitment to maintaining expert oversight of drugs within this category.

    Simple Explanation

    The FDA is keeping a special group of doctors and experts together until 2026 to make sure that medicines for skin and eyes are safe for people to use.